SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-060716
Filing Date
2015-07-13
Accepted
2015-07-13 19:28:04
Documents
2
Period of Report
2015-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4085
2 EX-24 DOCUMENT attachment1.htm EX-24 2187
  Complete submission text file 0001209191-15-060716.txt   7966
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Issuer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RADIUS HEALTH, INC. 201 BROADWAY, 6TH FL CAMBRIDGE MA 02139
Business Address
Fromkin Andrew J. (Reporting) CIK: 0001341896 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35953 | Film No.: 15986254